So are the times starting to show they’re changing at the federal level and beyond? Here are some tea leaves to read….
“In an effort to assist the United Nations in determining how cannabidiol (CBD), the non-intoxicating compound of the cannabis plant, fits in the mix of international drug treaties, the Food and Drug Administration [recently sought] comments from the [entire US] public concerning the ‘abuse potential, actual abuse, medical usefulness,’ and ‘trafficking’ of CBD.
The overall objective [was] to collect as much information as possible on the subject and turn it over to the World Health Organization (WHO), so it can decide where CBD belongs with respect to the ‘1971 Convention on Psychotropic Substances.’
Although there are not yet any FDA-approved CBD products on the market, FDA Deputy Commissioner Anna K. Abram, acknowledges that CBD ‘has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy.’
This statement is a big deal, especially considering that the government still considers every component of the cannabis plant to have “no known medicinal value.”
CBD is not the only outlaw substance being reviewed by world officials. The notice indicated that 16 other substances, including Fentanyl and Ketamine, were also being examined.
Unfortunately, the notice does not mean the US government is considering any kind of reschedule for CBD. The evaluation is strictly intended to provide guidance for WHO officials.”
Our take: Baby steps – but steps on a planetary scale. More of these, and bigger please….!!
#MMJ #UN #WHO #FDA #CBD #Reform #UtahNext #TRUCE